Greater Good IP Insider has been following the $7 million 11-patent license covering digital search algorithms discovered by the USC/Shoah Foundation. University of Southern California
Category: News
14 Articles on Patent Reform
Medical Pub Provides New Insight The summer 2010 issue of Medical Innovation & Business examines the economic impact of patent reform. It’s well worth taking
Patent “Plot” Thickens
EDN Takes a Fresh Look at NPEs In the current Electronic Design, Strategy, News, contributing editor Tam Harbert cuts to the heart of the NPE matter with a timely
Rampant IP Piracy is Hurting U.S.
China-U.S. IP Policy: Not a Two-Way Street The United States International Trade Commission (ITC) held a public hearing on June 15 and 16 that focused
Former Chief Patent Execs Speak Out
Defining Performance: No Simple Matter Former heads of intellectual property at Apple, IBM, H-P and Microsoft agree that using patents successfully is more elusive than
Free IP Webinar
Cost Effectiveness + Patent Quality Controlling costs and managing risk is paramount for patent stakeholders. They can be a challenge when the average cost of
The UK Drives IP Services
The British are Here! The UK holds a unique position in intellectual property world, especially publishing and services. At least several of the top IP publications
Demand Builds for Nortel Patents
Who Will Make Best Use of the IP? A lot of people are interested in what bankrupt Nortel will do with its valuable patent portfolio. In fact,
SEC Investigates Goldman Sachs Fraud
The Gold Standard No More? In a provocative IAM blog, Joff Wild asks will the Goldman Sachs brand be irreparably harmed from the SEC fraud
Patent Troll Defense
Insurer Must Provide Defense Coverage To Hyundai in “Troll” Dispute In a story that received scant media coverage, an appeals court has decided that two
Surveying the IP Landscape
Help to Measure the State of IP, 2010 The importance of IP rights to business performance and value has grown significantly over the past decade. But where does
Gene Patents on Trial
An Invention or a Discovery? Human genes have been called unpatentable and anti-competitive. Everyone from the ACLU to patients who demand cheaper tests are weighing in on the debate.
